Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ruth Sawadogo1, Joël Ouoba2, Dieudonné Ilboudo2

  • 1Institut supérieur des sciences de la santé (IN.S.SA), Université Nazi BONI (UNB), Bobo-Dioulasso, Burkina Faso. Agence nationale de régulation pharmaceutique (ANRP), ministère de la Santé, Ouagadougou, Burkina Faso.

Sante Publique (Vandoeuvre-Les-Nancy, France)
|February 13, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the COVID-19 pandemic on reported malaria incidence in children under five years of age in Cameroon: an interrupted time series analysis with regional heterogeneity (2017-2022).

Malaria journal·2026
Same author

A prioritised research agenda to inform the introduction and use of Lassa fever vaccines in West Africa.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Risk factors and population attributable fraction for large-for-gestational-age and macrosomic births in low- and middle-income countries between 2000 and 2025: a protocol for systematic review and meta-analysis.

BMJ open·2026
Same author

Science-policy translation for Lassa fever control in West Africa: a qualitative synthesis of regional evidence.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same author

Real-World Dynamic Patterns and Predictors of Antiretroviral Therapy Adherence Among Adults Living With HIV in Belgium: Evidence From Group-Based Trajectory Modeling.

Pharmacoepidemiology and drug safety·2026
Same author

Intra-action review of West African health Organization's response to the COVID-19 pandemic in the Economic Community of West African states (ECOWAS) region, 2020 - 2022.

BMC health services research·2026
Same journal

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same journal

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same journal

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same journal

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same journal

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same journal

Sante publique (Vandoeuvre-les-Nancy, France)·2026
See all related articles
This summary is machine-generated.

This study assessed COVID-19 vaccine safety in Burkina Faso, finding mostly mild adverse events following immunization (AEFIs). However, the overall AEFI reporting rate was low, indicating a need for enhanced vaccine safety monitoring.

Area of Science:

  • Public Health
  • Vaccinology
  • Pharmacovigilance
Keywords:
Adverse event following immunizationBurkina FasoCOVID-19 vaccinesVaccinationVigiBase

Related Experiment Videos